Shebani Sethi Named New NIMH Director
The appointment of a new director for the institute may shift federal research priorities toward metabolic psychiatry.
Updated on Oct. 27, 2026 in Mental Health
Live Poll
Should government science agencies prioritize traditional research experience when appointing new leadership?
Robert F. Kennedy Jr. has selected Shebani Sethi to serve as the new director of the National Institute of Mental Health (NIMH). This appointment fills a key vacancy within the National Institutes of Health, where many leadership roles have recently remained open.
Why it matters
The NIMH plays a central role in guiding mental health research funding and priorities in the United States. Changes in leadership can shift the focus of federally funded studies regarding the treatment and understanding of psychiatric conditions.
Recent leadership transitions have impacted the National Institutes of Health, which manages 27 distinct institutes and centers. At one point, over half of these directorships were vacant following a series of departures.
The players
Robert F. Kennedy Jr.
The political figure leading the selection process for key federal health appointments.
Shebani Sethi
The newly appointed NIMH director known for her work in metabolic psychiatry and dietary interventions.
Vikaas Sohal
A long-time laboratory director and NIMH grant recipient who was not selected for the leadership role.
The details
Shebani Sethi, who finished a psychiatry residency at Stanford and coined the term metabolic psychiatry in 2015, focuses on the use of ketogenic and other special diets to treat mental illnesses. In 2024, she published preliminary data from a trial examining the intersection of a ketogenic diet and schizophrenia medication. Unlike some predecessors, Sethi has not previously received an NIH grant.
Timeline
2013: Shebani Sethi earned her M.D. and Ph.D. degrees.
2015: Shebani Sethi coined the term metabolic psychiatry.
2024: Sethi published preliminary data from keto diet trials.
Health Landscape
This appointment marks a significant shift in the leadership profile of the NIH as it moves to fill widespread vacancies among its 27 institutes. It highlights a departure from traditional leadership requirements toward candidates aligned with the Make America Healthy Again movement.
This leadership change may influence which psychiatric treatment avenues receive federal research backing in the future. Patients interested in metabolic approaches to mental health should continue to discuss evolving treatment options with their own physician.
The takeaway
The appointment of a new NIMH director signals a potential pivot in federal mental health research priorities. Patients are encouraged to track how shifting federal funding influences the availability of new clinical trials and treatment guidelines for their specific conditions.
Further reading
For more on the latest research and policy updates in this field, visit our Mental Health section.
Source note: This article includes information reported by Energy Central.
Live Poll
Should government science agencies prioritize traditional research experience when appointing new leadership?
